Objective. To examine hepatitis C virus (HCV) seroprevalence among injection drug users in
4 US cities from 1994 through 2004. Methods. Demographic characteristics, behaviors, and …

Hepatitis C virus (HCV) is the principal cause of non-A, non-B hepatitis in the United States
(1, 3). Over 80% of those infected with HCV develop chronic liver disease, which may lead to …

Background: Time to hepatitis C virus (HCV) seroconversion in initially seronegative
injection drug users has not been directly measured, and public health planning would …

Effective methods to diminish the burden of hepatitis C virus (HCV) infection among injection
drug users (IDUs) require consideration of the epidemiology and natural history of both …

Between 1988 and 1996, the incidence of and risk factors for hepatitis C virus (HCV)
infection were studied in a cohort of injection drug users in Baltimore, Maryland. By second …

Injection drug users (IDUs) constitute the core of the hepatitis C epidemic in the developed
world. Four times more prevalent than HIV infection, hepatitis C virus (HCV) has been …

The prevalence, risk factors, and prevention opportunities of hepatitis C virus (HCV) infection
were studied in a large sample of 698 young adult injection drug users (IDUs) in Chicago …

Abstract Background Hepatitis C virus (HCV) infection, clearance, and reinfection are best
studied in injection drug users (IDUs), who have the highest incidence of HCV and are likely …

Previous studies suggest that most injection drug users (IDUs) become infected with
hepatitis C virus (HCV) and hepatitis B virus (HBV) soon after initiating drug use. The Urban …

We describe the prevalence of hepatitis C virus (HCV) infection among noninjection users of
heroin in Italy and compare the prevalence of HCV infection among noninjection drug users …